CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline.

Chron Respir Dis · 2020 · PMC7521048 · PMID 32969271

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

a trend toward significancep = 0.055so close (0.05 < p ≤ 0.1)

Among IPF patients, CA 19-9 was higher in slow than in rapid progressors with a trend toward significance (33vs17kU/L; p = 0.055).

also in 3,729 other papers

did not reach statistical significancep = 0.055so close (0.05 < p ≤ 0.1)

Interestingly, rapid progressors displayed lower serum levels of CA 19-9 compared to slow progressors, although this difference did not reach statistical significance (17 [3–70] kU/L vs. 33 [16–415] kU/L, p = 0.055 respectively) ( Figure 1B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.